US Patent 11286302 Anti-B7-H4 antibodies and immunoconjugates

Patent 11286302 was granted and assigned to Genentech on March, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Genentech

Current Assignee

Genentech

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11286302

Date of Patent

March 29, 2022

Patent Application Number

16043274

Date Filed

July 24, 2018

Patent Citations

‌

US Patent 10059768 Anti-B7-H4 antibodies and immunoconjugates

‌

US Patent 10150813 Anti-B7-H4 antibodies and immunoconjugates

Patent Citations Received

‌

US Patent 12134649 Anti-B7-H4 antibodies and immunoconjugates

Patent Primary Examiner

‌

Joanne Hama

The invention provides anti-B7-H4 antibodies and immunoconjugates and methods of using the same.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11286302 Anti-B7-H4 antibodies and immunoconjugates

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API